Showing 1 - 8 results of 8 for search 'Taweegrit Siripongboonsitti', query time: 0.08s Refine Results
  1. 1
    The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial)

    The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial) by Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Paruspak Payoong, Nithi Mahanonda

    Published 2023
    Loading…
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)

    A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV) by Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Panisadee Avirutnan, Kunlakanya Jitobaom, Prasert Auewarakul

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST)

    Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged... by Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Thachanun Porntharukcharoen, Supamas Sirisreetreerux, Thitapha Thongchai, Kamonwan Soonklang, Nithi Mahanonda

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

    The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study by Nuttakant Nontawong, Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Mana Boonpratoom, Nawin Krailassiri, Chayaporn Boonkhum, Kamonwan Soonklang, Yong Poovorawan, Nithi Mahanonda

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population

    Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population by Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Bothamai Dechates, Harnphadungkit Monprach, Gaidganok Sornsamdang, Kasiruck Wittayasak, Kamonwan Soonklang, Nithi Mahanonda

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

    Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study by Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

    Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines by Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich, Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

    The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study by Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin, Kriangkrai Tawinprai

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: